SC 13G: Apellis Pharmaceuticals, Inc.

Ticker: APLS · Form: SC 13G · Filed: Oct 18, 2024 · CIK: 1492422

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by Apellis Pharmaceuticals, Inc..

Risk Assessment

Risk Level: low

Filing Details

This Form SC 13G (Form SC 13G) was filed with the SEC on October 18, 2024 regarding Apellis Pharmaceuticals, Inc. (APLS).

View full filing on EDGAR

View Full Filing

View this SC 13G filing on SEC EDGAR

View on Read The Filing